Related Experiment Video

Updated: Aug 14, 2026

Yeast As a Chassis for Developing Functional Assays to Study Human P53
14:57

Yeast As a Chassis for Developing Functional Assays to Study Human P53

Published on: August 4, 2019

E2F3a stimulates proliferation, p53-independent apoptosis and carcinogenesis in a transgenic mouse model

Qiwei X Paulson1, Mark J McArthur, David G Johnson

  • 1Department of Carcinogenesis, University of Texas MD Anderson Cancer Center, Science Park Research Division, Smithville, Texas 78957, USA.

Cell Cycle (Georgetown, Tex.)
|December 13, 2005
PubMed

Insights

The retinoblastoma (Rb) tumor suppressor pathway is often disrupted in cancer, leading to E2F transcription factor deregulation. This study shows that E2F3a overexpression in mice causes skin cell hyperproliferation and enhances tumor development.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Retinoblastoma (Rb) tumor suppressor inactivation is common in human cancers, causing E2F transcription factor deregulation.
  • E2F3 is a key regulator of cell proliferation, and its amplification/overexpression is observed in some human tumors.

Purpose of the Study:

  • To investigate the role of E2F3a in tumor development using a transgenic mouse model.
  • To characterize the effects of E2F3a overexpression in epithelial tissues.

Main Methods:

  • Established transgenic mice expressing E2F3a under the keratin 5 (K5) promoter in epithelial tissues.
  • Analyzed phenotypes including cell proliferation, hyperplasia, apoptosis, and response to skin carcinogenesis.
  • Compared K5-E2F3a mice to those expressing E2F1 or E2F4.

Main Results:

  • Transgenic E2F3a expression induced epidermal hyperproliferation, hyperplasia, and p53-independent apoptosis.
  • E2F3a demonstrated weak oncogenic activity and significantly enhanced skin carcinogenesis.
  • K5-E2F3a mice exhibited distinct phenotypes compared to E2F1 and E2F4 transgenic models, notably unique apoptotic activity and lack of tumor suppressive properties.

Conclusions:

  • E2F3a plays a significant role in promoting cell proliferation and tumor development.
  • E2F3a possesses unique biological activities distinct from other E2F family members in this model.
  • The findings highlight E2F3a as a potential therapeutic target in cancers with Rb pathway alterations.

More Related Videos

Orthotopic Transplantation of Breast Tumors as Preclinical Models for Breast Cancer07:45

Orthotopic Transplantation of Breast Tumors as Preclinical Models for Breast Cancer

Published on: May 18, 2020

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...